With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections.
- Arctic ocean expedition advances climate modeling
- Metoclopramide inhibits proliferation of leukemia stem cells
- UC study: The dangers of drugged driving are outpacing drunk driving
- Partners in crime: genetic collaborator may influence severity of the rare disease, NGLY1
- Life-threatening complications during pregnancy: greater long-term risk of death